InspireMD Company Overview

CGuard TM market potential in stroke prevention InspireMD In 2016... 13 million people are estimated gloabally to have high grade carotid stenosis 2.2 million people were diagnosed with a high grade carotid stenosis (HGS) ~600,000 (30%) received surgical/stent stroke treatment in the same year There is an untapped market of at least 1.6 million patients who could be helped by CGuard™ Proportion of diagnosed HGCS patients who received treatment in 2016 2017 Health Research International Market Report 600,000 1,600,000 ■ Not treated ■ Treated .plus the undiagnosed patients estimated at more than 10 million 19

View entire presentation